Qiagen stock pre-market at EUR 44.99: molecular testing group

Published on 10/26/2026 at 07:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

QIAGEN develops molecular testing technologies for research and clinical applications. At Lang & Schwarz the stock trades pre-market at EUR 44.99 on October 26, 2026.

Business model and next date

Qiagen develops and supplies molecular testing technologies for research and clinical applications.
Qiagen is scheduled to report full third-quarter results on November 4, 2026.
Qiagen stock trades pre-market at EUR 44.99 at 7:37 a.m. CET at Lang & Schwarz on October 26, 2026.

Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte, klinisches Laborlicht — Qiagen N.V. (NL0012169213) Pipette tropft klare Flüssigkeit in sterile 96-Well-Platte im klinischen Labor, Illustration mit AI erstellt.

Qiagen develops and supplies molecular testing technologies for research and clinical applications, according to its investor-relations materials. Qiagen stock trades pre-market at EUR 44.99 at 7:37 a.m. CET at Lang & Schwarz on October 26, 2026.

Ahead of the Xetra open

The bid was EUR 44.91 and the ask was EUR 45.06. The further course from the Xetra open at 9:00 a.m. CET is shown by the continuously updated real-time quote of Qiagen stock.